Esteban Gomez

Pediatric Hematologist
Center for Inherited Blood Disorders
Orange, California, United States

Presentation(s):

• OC 02.3 - Etranacogene dezaparvovec hemophilia B gene therapy phase 2b trial final results: stable and durable FIX level expression over 5 years

  Saturday, June 22, 2024
  13:30 – 13:45 ICT

• PB1220 - Cardiovascular Risk Factors in a Large Multi-Institutional Cohort of Persons with Hemophilia

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT